APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatological Disorders Medications

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dermatological Disorders Medications Industry Growth and Trends Forecast to 2032

22 December 2025103 pages

Choose your research edition.

Industry ResearchDermatological Disorders Medications Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatological Disorders Medications Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Dermatological Disorders Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatological Disorders Medications Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatological Disorders Medications Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Dermatological Disorders Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dermatological Disorders Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dermatological Disorders Medications is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dermatological Disorders Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dermatological Disorders Medications include Novartis, Mylan Pharmaceuticals, Roche, Pfizer, GlaxoSmithKline, Sinclair Pharma, PharmaDerm, Galderma and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dermatological Disorders Medications market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dermatological Disorders Medications market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dermatological Disorders Medications market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dermatological Disorders Medications.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dermatological Disorders Medications market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dermatological Disorders Medications Market by Company

Novartis

Mylan Pharmaceuticals

Roche

Pfizer

GlaxoSmithKline

Sinclair Pharma

PharmaDerm

Galderma

Bristol-Myers Squibb

Bausch Health

Barrier Therapeutics

Almirall

Dermatological Disorders Medications Segment by Type

Prescription Drugs

Over-The-Counter Drugs

Dermatological Disorders Medications Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Dermatological Disorders Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatological Disorders Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatological Disorders Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatological Disorders Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dermatological Disorders Medications manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dermatological Disorders Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Prescription Drugs Table 2. Major Company of Over-The-Counter Drugs Table 3. Global Dermatological Disorders Medications Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dermatological Disorders Medications Sales by Type (2021-2026) & (k units) Table 5. Global Dermatological Disorders Medications Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dermatological Disorders Medications Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dermatological Disorders Medications Sales Market Share in Value by Type (2021-2026) Table 8. Global Dermatological Disorders Medications Price by Type (2021-2026) & (US$/unit) Table 9. Global Dermatological Disorders Medications Sales by Type (2027-2032) & (k units) Table 10. Global Dermatological Disorders Medications Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dermatological Disorders Medications Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dermatological Disorders Medications Sales Market Share in Value by Type (2027-2032) Table 13. Global Dermatological Disorders Medications Price by Type (2027-2032) & (US$/unit) Table 14. North America Dermatological Disorders Medications Sales by Type (2021-2026) & (k units) Table 15. North America Dermatological Disorders Medications Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dermatological Disorders Medications Sales by Type (2021-2026) & (k units) Table 17. Europe Dermatological Disorders Medications Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dermatological Disorders Medications Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Dermatological Disorders Medications Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dermatological Disorders Medications Sales by Type (2021-2026) & (k units) Table 21. Latin America Dermatological Disorders Medications Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dermatological Disorders Medications Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Dermatological Disorders Medications Sales by Type (2021-2026) & (US$ Million) Table 24. Dermatological Disorders Medications Industry Trends Table 25. Dermatological Disorders Medications Industry Drivers Table 26. Dermatological Disorders Medications Industry Opportunities and Challenges Table 27. Dermatological Disorders Medications Industry Restraints Table 28. Global Dermatological Disorders Medications Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dermatological Disorders Medications Revenue Market Share by Company (2021-2026) Table 30. Global Dermatological Disorders Medications Sales by Company (2021-2026) & (k units) Table 31. Global Dermatological Disorders Medications Sales Share by Company (2021-2026) Table 32. Global Dermatological Disorders Medications Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Dermatological Disorders Medications Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dermatological Disorders Medications Major Company Production Sites and Headquarters Table 35. Global Dermatological Disorders Medications Company, Product Type & Application Table 36. Global Dermatological Disorders Medications Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dermatological Disorders Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dermatological Disorders Medications Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dermatological Disorders Medications Sales by Region (2021-2026) & (k units) Table 41. Global Dermatological Disorders Medications Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dermatological Disorders Medications Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dermatological Disorders Medications Sales Market Share in Value by Region (2021-2026) Table 44. Global Dermatological Disorders Medications Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Dermatological Disorders Medications Sales by Region (2027-2032) & (k units) Table 46. Global Dermatological Disorders Medications Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dermatological Disorders Medications Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dermatological Disorders Medications Sales Market Share in Value by Region (2027-2032) Table 49. Global Dermatological Disorders Medications Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Dermatological Disorders Medications Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dermatological Disorders Medications Sales by Application (2021-2026) & (k units) Table 52. Global Dermatological Disorders Medications Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dermatological Disorders Medications Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dermatological Disorders Medications Sales Market Share in Value by Application (2021-2026) Table 55. Global Dermatological Disorders Medications Price by Application (2021-2026) & (US$/unit) Table 56. Global Dermatological Disorders Medications Sales by Application (2027-2032) & (k units) Table 57. Global Dermatological Disorders Medications Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dermatological Disorders Medications Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dermatological Disorders Medications Sales Market Share in Value by Application (2027-2032) Table 60. Global Dermatological Disorders Medications Price by Application (2027-2032) & (US$/unit) Table 61. North America Dermatological Disorders Medications Sales by Application (2021-2026) & (k units) Table 62. North America Dermatological Disorders Medications Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dermatological Disorders Medications Sales by Application (2021-2026) & (k units) Table 64. Europe Dermatological Disorders Medications Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dermatological Disorders Medications Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Dermatological Disorders Medications Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dermatological Disorders Medications Sales by Application (2021-2026) & (k units) Table 68. Latin America Dermatological Disorders Medications Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dermatological Disorders Medications Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Dermatological Disorders Medications Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novartis Dermatological Disorders Medications Product Portfolio Table 75. Novartis Recent Development Table 76. Mylan Pharmaceuticals Company Information Table 77. Mylan Pharmaceuticals Business Overview Table 78. Mylan Pharmaceuticals Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Mylan Pharmaceuticals Dermatological Disorders Medications Product Portfolio Table 80. Mylan Pharmaceuticals Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Roche Dermatological Disorders Medications Product Portfolio Table 85. Roche Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Pfizer Dermatological Disorders Medications Product Portfolio Table 90. Pfizer Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Dermatological Disorders Medications Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. Sinclair Pharma Company Information Table 97. Sinclair Pharma Business Overview Table 98. Sinclair Pharma Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Sinclair Pharma Dermatological Disorders Medications Product Portfolio Table 100. Sinclair Pharma Recent Development Table 101. PharmaDerm Company Information Table 102. PharmaDerm Business Overview Table 103. PharmaDerm Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. PharmaDerm Dermatological Disorders Medications Product Portfolio Table 105. PharmaDerm Recent Development Table 106. Galderma Company Information Table 107. Galderma Business Overview Table 108. Galderma Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Galderma Dermatological Disorders Medications Product Portfolio Table 110. Galderma Recent Development Table 111. Bristol-Myers Squibb Company Information Table 112. Bristol-Myers Squibb Business Overview Table 113. Bristol-Myers Squibb Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Bristol-Myers Squibb Dermatological Disorders Medications Product Portfolio Table 115. Bristol-Myers Squibb Recent Development Table 116. Bausch Health Company Information Table 117. Bausch Health Business Overview Table 118. Bausch Health Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Bausch Health Dermatological Disorders Medications Product Portfolio Table 120. Bausch Health Recent Development Table 121. Barrier Therapeutics Company Information Table 122. Barrier Therapeutics Business Overview Table 123. Barrier Therapeutics Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Barrier Therapeutics Dermatological Disorders Medications Product Portfolio Table 125. Barrier Therapeutics Recent Development Table 126. Almirall Company Information Table 127. Almirall Business Overview Table 128. Almirall Dermatological Disorders Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Almirall Dermatological Disorders Medications Product Portfolio Table 130. Almirall Recent Development Table 131. North America Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. North America Dermatological Disorders Medications Sales by Country (2021-2026) & (k units) Table 133. North America Dermatological Disorders Medications Sales Market Share by Country (2021-2026) Table 134. North America Dermatological Disorders Medications Sales Forecast by Country (2027-2032) & (k units) Table 135. North America Dermatological Disorders Medications Sales Market Share Forecast by Country (2027-2032) Table 136. North America Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Dermatological Disorders Medications Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Dermatological Disorders Medications Market Share by Country (2021-2026) Table 139. North America Dermatological Disorders Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Dermatological Disorders Medications Market Share Forecast by Country (2027-2032) Table 141. Europe Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Europe Dermatological Disorders Medications Sales by Country (2021-2026) & (k units) Table 143. Europe Dermatological Disorders Medications Sales Market Share by Country (2021-2026) Table 144. Europe Dermatological Disorders Medications Sales Forecast by Country (2027-2032) & (k units) Table 145. Europe Dermatological Disorders Medications Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Dermatological Disorders Medications Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Dermatological Disorders Medications Market Share by Country (2021-2026) Table 149. Europe Dermatological Disorders Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Dermatological Disorders Medications Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Dermatological Disorders Medications Sales by Country (2021-2026) & (k units) Table 153. Asia-Pacific Dermatological Disorders Medications Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Dermatological Disorders Medications Sales Forecast by Country (2027-2032) & (k units) Table 155. Asia-Pacific Dermatological Disorders Medications Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Dermatological Disorders Medications Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Dermatological Disorders Medications Market Share by Country (2021-2026) Table 159. Asia-Pacific Dermatological Disorders Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Dermatological Disorders Medications Market Share Forecast by Country (2027-2032) Table 161. Latin America Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Latin America Dermatological Disorders Medications Sales by Country (2021-2026) & (k units) Table 163. Latin America Dermatological Disorders Medications Sales Market Share by Country (2021-2026) Table 164. Latin America Dermatological Disorders Medications Sales Forecast by Country (2027-2032) & (k units) Table 165. Latin America Dermatological Disorders Medications Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Dermatological Disorders Medications Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Dermatological Disorders Medications Market Share by Country (2021-2026) Table 169. Latin America Dermatological Disorders Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Dermatological Disorders Medications Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Dermatological Disorders Medications Sales by Country (2021-2026) & (k units) Table 173. Middle East and Africa Dermatological Disorders Medications Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Dermatological Disorders Medications Sales Forecast by Country (2027-2032) & (k units) Table 175. Middle East and Africa Dermatological Disorders Medications Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Dermatological Disorders Medications Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Dermatological Disorders Medications Market Share by Country (2021-2026) Table 179. Middle East and Africa Dermatological Disorders Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Dermatological Disorders Medications Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Dermatological Disorders Medications Distributors List Table 184. Dermatological Disorders Medications Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Dermatological Disorders Medications Image Figure 2. Global Dermatological Disorders Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dermatological Disorders Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Dermatological Disorders Medications Sales (2021-2032) & (k units) Figure 5. Prescription Drugs Image Figure 6. Global Prescription Drugs Sales YoY Growth (2021-2032) & (k units) Figure 7. Over-The-Counter Drugs Image Figure 8. Global Over-The-Counter Drugs Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Dermatological Disorders Medications Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dermatological Disorders Medications Market Share by Type 2025 VS 2032 Figure 11. North America Dermatological Disorders Medications Sales Market Share in Volume by Type in 2025 Figure 12. North America Dermatological Disorders Medications Sales Market Share in Value by Type in 2025 Figure 13. Europe Dermatological Disorders Medications Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dermatological Disorders Medications Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dermatological Disorders Medications Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dermatological Disorders Medications Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dermatological Disorders Medications Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dermatological Disorders Medications Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dermatological Disorders Medications Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dermatological Disorders Medications Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dermatological Disorders Medications Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Online Pharmacies Image Figure 24. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Dermatological Disorders Medications Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Dermatological Disorders Medications Market Share by Application 2025 VS 2032 Figure 31. North America Dermatological Disorders Medications Sales Market Share in Volume by Application in 2025 Figure 32. North America Dermatological Disorders Medications Sales Market Share in Value by Application in 2025 Figure 33. Europe Dermatological Disorders Medications Sales Market Share in Volume by Application in 2025 Figure 34. Europe Dermatological Disorders Medications Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Dermatological Disorders Medications Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Dermatological Disorders Medications Sales Market Share in Value by Application in 2025 Figure 37. Latin America Dermatological Disorders Medications Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Dermatological Disorders Medications Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Dermatological Disorders Medications Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Dermatological Disorders Medications Sales Market Share in Value by Application in 2025 Figure 41. North America Dermatological Disorders Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Dermatological Disorders Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Dermatological Disorders Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Dermatological Disorders Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dermatological Disorders Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Dermatological Disorders Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dermatological Disorders Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Dermatological Disorders Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dermatological Disorders Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Dermatological Disorders Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dermatological Disorders Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Dermatological Disorders Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dermatological Disorders Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Dermatological Disorders Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dermatological Disorders Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Dermatological Disorders Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dermatological Disorders Medications Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Dermatological Disorders Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dermatological Disorders Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Dermatological Disorders Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Dermatological Disorders Medications Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Dermatological Disorders Medications Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drugs
  • Over-The-Counter Drugs
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Novartis
  • Mylan Pharmaceuticals
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Sinclair Pharma
  • PharmaDerm
  • Galderma
  • Bristol-Myers Squibb
  • Bausch Health
  • Barrier Therapeutics
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dermatological Disorders Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dermatological Disorders Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dermatological Disorders Medications Market by Type
  6. 1.3.1 Prescription Drugs
  7. 1.3.2 Over-The-Counter Drugs
  8. 1.4 Global Dermatological Disorders Medications Market Size by Type
  9. 1.4.1 Global Dermatological Disorders Medications Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dermatological Disorders Medications Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dermatological Disorders Medications Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dermatological Disorders Medications Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dermatological Disorders Medications Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dermatological Disorders Medications Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dermatological Disorders Medications Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dermatological Disorders Medications Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dermatological Disorders Medications Industry Trends
  2. 2.2 Dermatological Disorders Medications Industry Drivers
  3. 2.3 Dermatological Disorders Medications Industry Opportunities and Challenges
  4. 2.4 Dermatological Disorders Medications Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dermatological Disorders Medications Revenue (2021-2026)
  2. 3.2 Global Top Players by Dermatological Disorders Medications Sales (2021-2026)
  3. 3.3 Global Top Players by Dermatological Disorders Medications Price (2021-2026)
  4. 3.4 Global Dermatological Disorders Medications Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dermatological Disorders Medications Major Company Production Sites & Headquarters
  6. 3.6 Global Dermatological Disorders Medications Company, Product Type & Application
  7. 3.7 Global Dermatological Disorders Medications Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dermatological Disorders Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dermatological Disorders Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dermatological Disorders Medications Tier 1, Tier 2, and Tier 3
4 Dermatological Disorders Medications Regional Status and Outlook
  1. 4.1 Global Dermatological Disorders Medications Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dermatological Disorders Medications Historic Market Size by Region
  3. 4.2.1 Global Dermatological Disorders Medications Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dermatological Disorders Medications Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dermatological Disorders Medications Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dermatological Disorders Medications Forecasted Market Size by Region
  7. 4.3.1 Global Dermatological Disorders Medications Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dermatological Disorders Medications Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dermatological Disorders Medications Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dermatological Disorders Medications by Application
  1. 5.1 Dermatological Disorders Medications Market by Application
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Dermatological Disorders Medications Market Size by Application
  6. 5.2.1 Global Dermatological Disorders Medications Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dermatological Disorders Medications Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dermatological Disorders Medications Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dermatological Disorders Medications Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dermatological Disorders Medications Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dermatological Disorders Medications Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dermatological Disorders Medications Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dermatological Disorders Medications Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Dermatological Disorders Medications Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Mylan Pharmaceuticals
  8. 6.2.1 Mylan Pharmaceuticals Company Information
  9. 6.2.2 Mylan Pharmaceuticals Business Overview
  10. 6.2.3 Mylan Pharmaceuticals Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Pharmaceuticals Dermatological Disorders Medications Product Portfolio
  12. 6.2.5 Mylan Pharmaceuticals Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche Dermatological Disorders Medications Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Dermatological Disorders Medications Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Dermatological Disorders Medications Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Sinclair Pharma
  32. 6.6.1 Sinclair Pharma Company Information
  33. 6.6.2 Sinclair Pharma Business Overview
  34. 6.6.3 Sinclair Pharma Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sinclair Pharma Dermatological Disorders Medications Product Portfolio
  36. 6.6.5 Sinclair Pharma Recent Developments
  37. 6.7 PharmaDerm
  38. 6.7.1 PharmaDerm Company Information
  39. 6.7.2 PharmaDerm Business Overview
  40. 6.7.3 PharmaDerm Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 PharmaDerm Dermatological Disorders Medications Product Portfolio
  42. 6.7.5 PharmaDerm Recent Developments
  43. 6.8 Galderma
  44. 6.8.1 Galderma Company Information
  45. 6.8.2 Galderma Business Overview
  46. 6.8.3 Galderma Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Galderma Dermatological Disorders Medications Product Portfolio
  48. 6.8.5 Galderma Recent Developments
  49. 6.9 Bristol-Myers Squibb
  50. 6.9.1 Bristol-Myers Squibb Company Information
  51. 6.9.2 Bristol-Myers Squibb Business Overview
  52. 6.9.3 Bristol-Myers Squibb Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bristol-Myers Squibb Dermatological Disorders Medications Product Portfolio
  54. 6.9.5 Bristol-Myers Squibb Recent Developments
  55. 6.10 Bausch Health
  56. 6.10.1 Bausch Health Company Information
  57. 6.10.2 Bausch Health Business Overview
  58. 6.10.3 Bausch Health Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bausch Health Dermatological Disorders Medications Product Portfolio
  60. 6.10.5 Bausch Health Recent Developments
  61. 6.11 Barrier Therapeutics
  62. 6.11.1 Barrier Therapeutics Company Information
  63. 6.11.2 Barrier Therapeutics Business Overview
  64. 6.11.3 Barrier Therapeutics Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Barrier Therapeutics Dermatological Disorders Medications Product Portfolio
  66. 6.11.5 Barrier Therapeutics Recent Developments
  67. 6.12 Almirall
  68. 6.12.1 Almirall Company Information
  69. 6.12.2 Almirall Business Overview
  70. 6.12.3 Almirall Dermatological Disorders Medications Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Almirall Dermatological Disorders Medications Product Portfolio
  72. 6.12.5 Almirall Recent Developments
7 North America by Country
  1. 7.1 North America Dermatological Disorders Medications Sales by Country
  2. 7.1.1 North America Dermatological Disorders Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dermatological Disorders Medications Sales by Country (2021-2026)
  4. 7.1.3 North America Dermatological Disorders Medications Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dermatological Disorders Medications Market Size by Country
  6. 7.2.1 North America Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dermatological Disorders Medications Market Size by Country (2021-2026)
  8. 7.2.3 North America Dermatological Disorders Medications Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dermatological Disorders Medications Sales by Country
  2. 8.1.1 Europe Dermatological Disorders Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dermatological Disorders Medications Sales by Country (2021-2026)
  4. 8.1.3 Europe Dermatological Disorders Medications Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dermatological Disorders Medications Market Size by Country
  6. 8.2.1 Europe Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dermatological Disorders Medications Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dermatological Disorders Medications Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dermatological Disorders Medications Sales by Country
  2. 9.1.1 Asia-Pacific Dermatological Disorders Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dermatological Disorders Medications Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dermatological Disorders Medications Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dermatological Disorders Medications Market Size by Country
  6. 9.2.1 Asia-Pacific Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dermatological Disorders Medications Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dermatological Disorders Medications Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dermatological Disorders Medications Sales by Country
  2. 10.1.1 South America Dermatological Disorders Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dermatological Disorders Medications Sales by Country (2021-2026)
  4. 10.1.3 South America Dermatological Disorders Medications Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dermatological Disorders Medications Market Size by Country
  6. 10.2.1 South America Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dermatological Disorders Medications Market Size by Country (2021-2026)
  8. 10.2.3 South America Dermatological Disorders Medications Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dermatological Disorders Medications Sales by Country
  2. 11.1.1 Middle East and Africa Dermatological Disorders Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dermatological Disorders Medications Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dermatological Disorders Medications Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dermatological Disorders Medications Market Size by Country
  6. 11.2.1 Middle East and Africa Dermatological Disorders Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dermatological Disorders Medications Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dermatological Disorders Medications Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dermatological Disorders Medications Value Chain Analysis
  2. 12.1.1 Dermatological Disorders Medications Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dermatological Disorders Medications Production Mode & Process
  7. 12.2 Dermatological Disorders Medications Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dermatological Disorders Medications Distributors
  10. 12.2.3 Dermatological Disorders Medications Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst